tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Beijing Chunlizhengda Medical Instruments Releases Q3 2025 Financial Results

Story Highlights
  • Beijing Chunlizhengda operates in the medical instruments industry in China.
  • The company released its unaudited Q3 2025 financial results, highlighting performance and investment risks.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Beijing Chunlizhengda Medical Instruments Releases Q3 2025 Financial Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has issued an update.

Beijing Chunlizhengda Medical Instruments Co., Ltd. has released its unaudited financial results for the third quarter of 2025, prepared according to Chinese Accounting Standards. The report highlights the company’s financial performance over the nine months ending September 30, 2025, and advises investors to be aware of potential investment risks. The report is available in both Chinese and English, with the Chinese version taking precedence in case of discrepancies.

The most recent analyst rating on (HK:1858) stock is a Hold with a HK$17.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.

More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H

Beijing Chunlizhengda Medical Instruments Co., Ltd. is a joint stock limited company incorporated in China, operating in the medical instruments industry. The company focuses on the production and distribution of medical devices, with a market presence in Hong Kong and Shanghai stock exchanges.

Average Trading Volume: 2,061,478

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.81B

For an in-depth examination of 1858 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1